Skip to content

Clinical trials

Thrombocythemia, Essential trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20132
20142
20191
20231
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Incyte Corporation3
CTI BioPharma2
AbbVie1
Constellation Pharmaceuticals1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Université Catholique de Louvain1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential14
Primary Myelofibrosis12
Myeloproliferative Disorders11
Polycythemia Vera9
Leukemia, Myeloid, Acute5
Leukemia, Myelomonocytic, Chronic5
Neoplasms5
Blast Crisis4
Bone Marrow Diseases4
Burkitt Lymphoma4

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.